Elizabeth Franzmann, M.D. is Vigilant Biosciences’ Scientific Founder & Scientific Advisor. Her innovative clinical research on selective salivary biomarkers for head and neck squamous cell carcinoma serves as the foundation for Vigilant Biosciences’ product line. Dr. Franzmann is certified by the American Board of Otolaryngology and a Fellow of the American College of Surgeons. She is a Professor of Otolaryngology at the University of Miami, Miller School of Medicine specializing in head and neck surgery. She has been recognized as one of the “Best Doctors in America”. Over the past decade, she has worked in close partnership with Vigilant Biosciences, translating bench research into solutions that address unmet patient needs. Her work has been funded by foundations, state and federal agencies with numerous resulting patents and publications in well-respected, and peer-reviewed journals.
Dr. Franzmann earned a Bachelor of Science and Doctorate of Medicine at the University of California, Los Angeles.